There were a number of stocks that managed to deliver notable gains yesterday, and one of those was the Ludwig Enterprises Inc. (OTC:LUDG) stock, which rallied by 10%. The rally was triggered by a key new announcement from the biotech firm.
Provisional Patent Update
On Thursday, Ludwig Enterprises announced that it had submitted a provisional patent for its pathbreaking cancer detection methodology titled mRNAs Differentially Expressed in Cancer. “It was a significant new development given the implication of the method.
The innovation from Ludwig Enterprises analyzes six combinations of mRNA genes and has already demonstrated a strong rise in sensitivity as well as specificity in the detection of breast cancer in comparison to the usual methods.
Vital Details and Name Change
In the news release, it was noted that Ludwig Enterprises was already doing well in the genetic breast cancer screening space, but the latest findings from the methodology delivered unprecedented results.
The screening test was not only described as innovative but also non-invasive, both of which would provide people with the power to take their medical care into their own hands and possibly help in early detection. Additionally, Ludwig Enterprises also announced that it had made plans to change its name to Revealia Inc., and the change would go through following the regulatory processes as well as the related change in the ticker symbol.
Management Comment
“We were already doing well, but this is an incredible performance the likes of which we haven’t seen in the genetic breast cancer screening test market,” stated Marvin S. Hausman, MD, CSO. Our innovative and non-invasive screening test empowers people to be proactive with their medical care and potentially detect health issues early on.”
